Utah Medical Products
(NASDAQ) UTMD
Utah Medical Products Financials at a Glance
Market Cap
$225.02M
Revenue (TTM)
$38.52M
Net Income (TTM)
$11.29M
EPS (TTM)
$3.48
P/E Ratio
20.30
Dividend
$1.23
Beta (Volatility)
0.53 (Low)
Dividend
$1.23
Beta (Volatility)
0.53 (Low)
Price
$71.25
Volume
330
Open
$69.99
Price
$71.25
Volume
330
Open
$69.99
Previous Close
$71.25
Daily Range
$69.99 - $71.86
52-Week Range
$51.26 - $71.86
Dividend
$1.23
Beta (Volatility)
0.53 (Low)
Price
$71.25
Volume
330
Open
$69.99
Previous Close
$71.25
Daily Range
$69.99 - $71.86
52-Week Range
$51.26 - $71.86
UTMD News
5 Top Micro-Cap Stocks
UTMD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Utah Medical Products
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
183
CEO
Kevin Leighton Cornwell, MBA
Website
www.utahmed.comHeadquarters
Midvale, UT 84047-1048, US
UTMD Financials
Key Financial Metrics (TTM)
Gross Margin
53%
Operating Margin
30%
Net Income Margin
29%
Return on Equity
10%
Return on Capital
10%
Return on Assets
9%
Earnings Yield
4.93%
Dividend Yield
0.02%
Payout Ratio
35.29%
Stock Overview
Market Cap
$225.02M
Shares Outstanding
3.19M
Volume
330
Short Interest
0.00%
Avg. Volume
15.23K
Financials (TTM)
Gross Profit
$19.88M
Operating Income
$11.40M
EBITDA
$17.06M
Operating Cash Flow
$14.69M
Capital Expenditure
$371.00K
Free Cash Flow
$14.32M
Cash & ST Invst.
$85.76M
Total Debt
$225.00K
Utah Medical Products Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$9.04M
-1.2%
Gross Profit
$4.73M
-11.1%
Gross Margin
52.31%
N/A
Market Cap
$225.02M
N/A
Market Cap/Employee
$1.45M
N/A
Employees
155
N/A
Net Income
$2.56M
-11.6%
EBITDA
$3.85M
-3.3%
Quarterly Fundamentals
Net Cash
$85.53M
+3.4%
Accounts Receivable
$3.52M
-14.0%
Inventory
$7.93M
-10.0%
Long Term Debt
$225.00K
-20.2%
Short Term Debt
$0.00
N/A
Return on Assets
9.21%
N/A
Return on Invested Capital
9.51%
N/A
Free Cash Flow
$3.37M
+15.0%
Operating Cash Flow
$3.48M
+18.4%